Targeted therapy for non-small cell lung cancer: current standards and the promise of the future - Chan - Translational Lung Cancer Research
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
Locations of MET exon 14 genomic alterations found in sarcomatoid... | Download Scientific Diagram
Lung cancer with MET exon 14 skipping mutation | LCTT
Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro - Journal of Thoracic Oncology
Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: A review of preclinical and clinical studies - Cancer Treatment Reviews
Overcoming therapy resistance in EGFR-mutant lung cancer | Nature Cancer
Drugs in the Pipeline: Non-Small-Cell Lung Cancer
Biomarker Testing | Lung Cancer Initiative
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews
Frontiers | Co-Occurring Potentially Actionable Oncogenic Drivers in Non-Small Cell Lung Cancer | Oncology
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - Journal of Thoracic Oncology
Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exo | LCTT
Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer - Lung Cancer
Biomarkers in Lung Cancer: Integration with Radiogenomics Data | IntechOpen
Toward personalized treatment approaches for non-small-cell lung cancer | Nature Medicine
Lung cancer - The Lancet
Diagnosis and Discussion -- Case 1068
Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY
MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non–small-cell Lung Cancer - Clinical Lung Cancer
Targeting the MET Pathway for Lung Cancer Treatments, Biomarkers
